# Governance Gate — Advanced Bio-Quantum Experiments (Closeout Memo)

**Task:** b2008e8c-bafd-41e6-9e34-bd0e0aa35b50 · **Reviewer:** agent-legal-manager · **Status:** GO-WITH-CONDITIONS
**Date:** 2026-10-05 (fresh review; every criterion checkable on the repo; no stale-doc numbers)
**Claim tags per house standard:** (a) measured / (b) interpretation / (c) speculation.
**Companion docs:** `docs/artifacts/compliance/GOVERNANCE_GATE_BIO_QUANTUM.md` (full criteria, §1–§5) and `docs/artifacts/compliance/ORIGINALITY_AUDIT.md` (ownership/dependency evidence).

---

## 0. Scope — the three queued experiments

| # | Experiment | Highest-risk axis |
|---|---|---|
| E1 | **Virtual Cancer Cell / Cancer-Hypothesis Generation** (in-silico "effectiveness" modeling on simulated cells; public bio-APIs as reference input) | Medical claims + data ownership |
| E2 | **Genetic Time Reversal via Anyonic DNA Repair (simulation)** (braid-pathway analogy on DNA-repair pathways) | Medical/biological claims + deployment boundary |
| E3 | **Bio-Quantum Transducer (BQT) / 41.02 Hz bio-resonance** (spectral-detection event, "sentience trigger" naming) | Health/device claims + privacy if real bio signals ever enter |

> **Assumption flag (b):** this trio is the best-evidence mapping from the repo and the business plan (see companion doc §0). If the lead's "three" differ, the gates below apply unchanged per experiment — re-pointing the table does not require re-review of the framework.

---

## (A) Pass/fail criteria — an experiment moves backlog → in-progress ONLY if ALL are true

**A1. Medical-claim boundary (⛔ FAIL blocks).** Outputs are framed as **simulation/model outputs, not medical facts** — "simulated", "model estimate", "in-silico hypothesis" only; never "treats", "cures", "effective against", "diagnoses", "repairs" as a claim. Named model metrics (e.g., "simulated effectiveness score") are allowed **only** if the deliverable states they are not clinical claims. (a)

**A2. No clinical-validation claim (⛔ FAIL).** Nothing implies FDA/EMA/clinical-trial equivalence, "ready for patients", or any regulatory approval. (a)

**A3. No real human bio-data (⛔ FAIL).** No real-patient, human genetic, or real bio-signal data anywhere in the experiment; synthetic/generated samples and public **reference** sequences only. Any future real-data ingestion requires a new DPIA gate + owner approval (see §C6). (a)

**A4. No hardware/biological-effect claims (⛔ FAIL).** Simulation-only; no physical device, wet-lab protocol, or human-subject contact. "Quantum" = quantum-inspired math, **exact classical simulation** — no quantum hardware. The 41.02 Hz "sentience trigger" is a spectral-detection event / design metaphor, not consciousness or bio-resonance. (a)

**A5. Privacy & provenance (⛔ FAIL).** Zero PII/health/genetic/biometric collection; server stores no raw seeds and no person-linked artifacts (digest-only seed logging — current `rnd_battery.py` policy (a) — is the approved pattern). Each dataset/API used has documented source + license/TOS; no third-party corpus redistributed inside product artifacts without attribution. (a)

**A6. Ownership (required, verified).** Code, math, and generated outputs are owner-owned originals; no third-party quantum/LLM SDKs or wrappers (verified by import audit in `ORIGINALITY_AUDIT.md`); the 3-seed key stays owner-controlled, derived instances only. Third-party data is an **input**, not a component of owned IP. (a)

**A7. Reproducibility & durability (required).** Claims tagged (a)/(b)/(c); approved numbers re-verifiable by fresh run; artifact committed to git before task closes (this memo is the durability commit). (a)

### Per-experiment verdict matrix

| Experiment | A1 | A2 | A3 | A4 | A5 | A6 | A7 | Verdict |
|---|---|---|---|---|---|---|---|---|
| E1 Virtual Cancer Cell | PASS* | PASS | PASS | PASS | PASS | PASS | PASS | **CONDITIONAL** |
| E2 Genetic Time Reversal | PASS* | PASS | PASS | PASS | PASS | PASS | PASS | **CONDITIONAL** |
| E3 BQT / 41.02 Hz | PASS | PASS | PASS | PASS | PASS | PASS | PASS | **CONDITIONAL** |

*E1/E2 currently use risk language in repo artifacts (cancer "effectiveness", DNA-"repair"); that language must be re-framed as named model metrics / mathematical analogy per A1 before in-progress. (a)

- **GO** = all A1–A7 pass; task may go to in-progress immediately.
- **CONDITIONAL** = passes once disclaimer language (§B) is attached to the task/deliverable and any risk-language re-framing is done; in-progress only after lead confirms.
- **NO-GO** = any immediate A1/A2/A3/A4 FAIL; task stays backlog until the claim is re-scoped.

---

## (B) Required disclaimer language — VERBATIM, paste into lab UI, README, and API responses

> **Not a medical device.** Outputs are in-silico simulations of an owned deterministic model family. They are **not** medical advice, diagnosis, treatment recommendations, or proof of clinical efficacy, and they have **no regulatory approval**. No real human health, genetic, or biometric data is collected or processed. Nothing herein deploys to patients, clinical settings, or physical hardware. "Quantum" refers to quantum-inspired mathematics and exact classical simulation — no quantum-computing hardware is involved. (a)

Per-experiment one-liners (append to the block):
- **E1:** "Cancer/treatment language is a named model metric (simulated effectiveness), not a clinical claim." (a)
- **E2:** "'DNA repair' describes a mathematical braid-pathway analogy; no biological or genetic intervention is performed or implied." (a)
- **E3:** "The 41.02 Hz 'sentience trigger' is a spectral-detection event; it is a design metaphor, not a consciousness or bio-resonance claim." (a)

The R&D-battery `honest_ceiling` string remains the approved full-length variant for API responses.

---

## (C) Boundaries the team must not cross

1. **No cure/treat/diagnose language as a claim** — in titles, UI copy, READMEs, API responses, or PR descriptions. Named model metrics are fine only with the E1 reframe. (⛔ absolute)
2. **No regulatory or clinical-equivalence statements** — no FDA/EMA/CE/trial claims, express or implied. (⛔ absolute)
3. **No real human health/genetic/biometric data** — synthetic and public reference sequences only; no per-person storage or mapping. (⛔ absolute)
4. **No hardware, wet-lab, or deployment** — no physical device, no patient/clinical contact, no bio-signal capture from people. BQT stays a theoretical/layout proposal; build-like instructions carry the "concept only, no hardware" tag. (⛔ absolute)
5. **No consciousness/sentience claims** — "sentience trigger" is a design metaphor for a spectral-detection event (repo already complies (a)). (⛔ absolute)
6. **No raw-seed or person-linked storage** — digest-only provenance (current policy (a)); owner keeps the 3-seed key. (⛔ absolute)
7. **No decipherment claims without a bilingual** — structure ≠ meaning (house standard; applies to the scripts track, not bio track, but is team-wide). (⛔ absolute)
8. **No external validation overclaim** — one blind prediction is a data point, not validation; everything is exact classical simulation. (⛔ absolute)

---

## (D) Sign-off & blocks

**Sign-off (legal manager):** the gate framework is complete and applied on fresh repo evidence. Verdict **GO-WITH-CONDITIONS**: E1–E3 may proceed if (i) the lead confirms the E1/E2/E3 mapping in §0, and (ii) each task description embeds the §B language and any A1 reframing. No red flag blocks the gate itself.

**Specific items requiring owner/lead decision before downstream milestones (not gate blockers):**
1. **Legacy torch/transformers scripts** (`train_jarvis.py`, `train_llm.py`, `convert_to_gguf.py` — root, tracked, not product core): decide relocate to `legacy/`, delete, or document as dev-only. (b)
2. **"J.A.R.V.I.S." trademark** — Marvel/Disney IP; owner decision on rebrand/additional clearance. (c)
3. **New data-license risk if the scripts/corpus track grows** — include third-party corpus ToS review in future PRs touching data files. (b)

Author: agent-legal-manager · Tags (a)/(b)/(c) throughout · Verifiable by fresh grep/run on the repo.